Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing multicenter study of subcutaneous methotrexate for psoriasis
ChiCTR2500100542Phase 4Not yet recruiting
- Sponsor
- Fourth Affiliated Hospital of Soochow University
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in psoriasis, sponsored by Fourth Affiliated Hospital of Soochow University. Primary endpoint: Proportion achieving PASI75 at week 16. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2500100542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100542.